ClinicalTrials.Veeva

Menu

Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator?

E

Edgardo Szyld

Status and phase

Completed
Phase 3

Conditions

Resuscitation

Treatments

Device: T-piece resuscitator Neopuff TM
Device: Self Inflating Bag with PEEP
Device: Self Inflating Bag without PEEP

Study type

Interventional

Funder types

Other

Identifiers

NCT00443118
Fundasamin 102

Details and patient eligibility

About

A multicenter cross-over cluster randomized controlled trial protocol study in newborn infants ≥ 26 weeks gestational age requiring assisted ventilation (positive pressure ventilation [PPV]) for resuscitation in the delivery room comparing a T-piece resuscitator device versus resuscitation bag.

Full description

Design: A multicenter cross-over cluster randomized controlled trial. Our hypothesis is based on the assumption that ventilating depressed newborns with a T-piece resuscitator will be more effective than SIB by increasing the proportion of resuscitated newborns with heart rate (HR) ≥ 100 beats per minute (bpm) at two minutes of life as a proxy for successful resuscitation.

Population: Newborn infants ≥ 26 weeks gestational age requiring assisted ventilation (PPV) for resuscitation in the delivery room.

(need for assisted ventilation at positive pressure: Heart Rate [HR] < 100 beats per minute [bpm], apnea, gasping, cyanosis and/or hypotonia)

Intervention: PPV will be performed with a T-piece resuscitator (Neopuff® group) with positive end expiratory pressure.

Control: PPV will be performed with a self inflating bag (SIB group) with and without PEEP.

Both devices will be used with face masks, and a peak inspiratory pressure (PIP) of 25 cm H2O will be used to begin ventilation with PEEP of 0 cm H2O in the subgroup without PEEP valve, 5 cm H2O in the subgroup with PEEP valve in the SIB group, and 5 cm H2O in the Neopuff® group.

Objective: To compare the effectiveness of both instruments in reaching a heart rate of ≥ 100 bpm in depressed newborns of ≥ 26 weeks' gestational age (GA) after the initiation of positive pressure ventilation (PPV) with face mask.

Primary Outcome: Proportion of newborns with HR ≥ 100 bpm at 2 minutes of life.

Type of Comparison: Which of the two devices Neopuff TM or Self Inflating Bag (NP/SIB)will be more effective for ventilation of the newborn, by increasing the proportion of resuscitated newborns with heart rate (HR) ≥ 100 beats per minute (bpm) at two minutes of life as a proxy for successful resuscitation.

Enrollment

1,032 patients

Sex

All

Ages

Under 2 minutes old

Volunteers

No Healthy Volunteers

Inclusion criteria

Live-born infants of ≥ 26 weeks' GA with HR < 100 bpm requiring resuscitation with positive pressure ventilation with mask in the delivery room according to the current AAP/AHA recommendations

Exclusion criteria

Infants requiring intubation from birth. Newborns of < 26 weeks´ GA. Newborns presenting major congenital malformations. Multiple births. Problems (difficulty or malfunctioning) with the device assigned.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,032 participants in 3 patient groups

Neopuff TM with PEEP
Active Comparator group
Description:
Newborns ventilated for neonatal resuscitation using Neopuff TM with PEEP
Treatment:
Device: T-piece resuscitator Neopuff TM
Self Inflating Bag with PEEP
Active Comparator group
Description:
Newborns ventilated for neonatal resuscitation using Self Inflating Bag with PEEP valve attached
Treatment:
Device: Self Inflating Bag with PEEP
Self Inflating Bag without PEEP
Active Comparator group
Description:
Newborns ventilated for neonatal resuscitationusing Self Inflating Bag without PEEP valve attached
Treatment:
Device: Self Inflating Bag without PEEP

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems